Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT01563731
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT01563731
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Russia
- Registry status
- Completed
Technical summary
Registry record NCT01563731. Randomized; no masking; primary purpose prevention. Start 2013-04 (actual); primary completion 2020-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives
- Acronym
- ESH-CHL-SHOT
- Condition
- Stroke
- Condition
- Transient Ischemic Attack
- Condition
- Hypertension
- Intervention (Drug)
- all approved antihypertensive drugs; all approved statins
- Lead sponsor
- Istituto Auxologico Italiano
- Collaborator
- European Society of Hypertension
- Collaborator
- Chinese Hypertension League
Record details
- Record id
cardio:ct-nct01563731- Content hash
80f01545bfb7eaae5ae544aa4f842ba10ade8d297faa3cc14b66969ce2a87c67